Literature DB >> 2884103

A single point mutation in erbA restores the erythroid transforming potential of a mutant avian erythroblastosis virus (AEV) defective in both erbA and erbB oncogenes.

K Damm, H Beug, T Graf, B Vennström.   

Abstract

We have characterized the v-erbA and v-erbB oncogenes of td359, a transformation-defective mutant of avian erythroblastosis virus (AEV) unable to transform erythroblasts, and the revertant r12, obtained after in vivo passage of the mutant. Molecular cloning, sequencing, construction of chimeric viruses and testing of their oncogenic capacities revealed that both oncogenes of td359 are mutated and biologically defective. The r12 virus, although still containing a mutant v-erbB gene, recovered its erythroid transforming potential by acquiring a highly active gag-erbA gene. These results demonstrate that two co-operating oncogenes, an active v-erbA and a defective v-erbB, can transform a cell type not transformed by either oncogene alone. Furthermore, a single amino acid substitution inactivated the td359 v-erbA protein and we show that its reversion led to the reactivation of the protein. This lesion is located in the same region as several previously described inactivating mutations of glucocorticoid receptors, suggesting that the structure/function relationship of the virally transduced form of the c-erbA/thyroid hormone receptor is closely similar to that of steroid hormone receptors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2884103      PMCID: PMC553406          DOI: 10.1002/j.1460-2075.1987.tb04765.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  32 in total

1.  Chicken hematopoietic cells transformed by seven strains of defective avian leukemia viruses display three distinct phenotypes of differentiation.

Authors:  H Beug; A von Kirchbach; G Döderlein; J F Conscience; T Graf
Journal:  Cell       Date:  1979-10       Impact factor: 41.582

2.  Lambdoid phages that simplify the recovery of in vitro recombinants.

Authors:  N E Murray; W J Brammar; K Murray
Journal:  Mol Gen Genet       Date:  1977-01-07

3.  Hematopoietic cells transformed in vitro by REVT avian reticuloendotheliosis virus express characteristics of very immature lymphoid cells.

Authors:  H Beug; H Müller; S Grieser; G Doederlein; T Graf
Journal:  Virology       Date:  1981-12       Impact factor: 3.616

4.  Mutant avian erythroblastosis virus with restricted target cell specificity.

Authors:  B Royer-Pokora; S Grieser; H Beug; T Graf
Journal:  Nature       Date:  1979-12-13       Impact factor: 49.962

5.  Transforming capacities of avian erythroblastosis virus mutants deleted in the erbA or erbB oncogenes.

Authors:  L Frykberg; S Palmieri; H Beug; T Graf; M J Hayman; B Vennström
Journal:  Cell       Date:  1983-01       Impact factor: 41.582

6.  Transformation of both erythroid and myeloid cells by E26, an avian leukemia virus that contains the myb gene.

Authors:  K Radke; H Beug; S Kornfeld; T Graf
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

7.  Mutant of avian erythroblastosis virus defective for erythroblast transformation: deletion in the erb portion of p75 suggests function of the protein in leukemogenesis.

Authors:  H Beug; G Kitchener; G Doederlein; T Graf; M J Hayman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

8.  Analysis of avian leukosis virus DNA and RNA in bursal tumours: viral gene expression is not required for maintenance of the tumor state.

Authors:  G S Payne; S A Courtneidge; L B Crittenden; A M Fadly; J M Bishop; H E Varmus
Journal:  Cell       Date:  1981-02       Impact factor: 41.582

9.  Molecular cloning of the avian erythroblastosis virus genome and recovery of oncogenic virus by transfection of chicken cells.

Authors:  B Vennström; L Fanshier; C Moscovici; J M Bishop
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  31 in total

1.  Unique forms of human and mouse nuclear receptor corepressor SMRT.

Authors:  P Ordentlich; M Downes; W Xie; A Genin; N B Spinner; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

2.  The C'-terminal interaction domain of the thyroid hormone receptor confers the ability of the DNA site to dictate positive or negative transcriptional activity.

Authors:  J M Holloway; C K Glass; S Adler; C A Nelson; M G Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

3.  Multiple mutations contribute to repression by the v-Erb A oncoprotein.

Authors:  Sangho Lee; Martin L Privalsky
Journal:  Oncogene       Date:  2005-10-13       Impact factor: 9.867

4.  Ontogeny of the v-erbA oncoprotein from the thyroid hormone receptor: an alteration in the DNA binding domain plays a role crucial for v-erbA function.

Authors:  B G Bonde; M Sharif; M L Privalsky
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

5.  Epidermal growth factor receptor cytoplasmic domain mutations trigger ligand-independent transformation.

Authors:  S Massoglia; A Gray; T J Dull; S Munemitsu; H J Kun; J Schlessinger; A Ullrich
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

6.  The lack of transcriptional activation of the v-erbA oncogene is in part due to a mutation present in the DNA binding domain of the protein.

Authors:  H de Verneuil; D Metzger
Journal:  Nucleic Acids Res       Date:  1990-08-11       Impact factor: 16.971

7.  Ectopic expression of the erythrocyte band 3 anion exchange protein, using a new avian retrovirus vector.

Authors:  S Fuerstenberg; H Beug; M Introna; K Khazaie; A Muñoz; S Ness; K Nordström; J Sap; I Stanley; M Zenke
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

8.  SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers.

Authors:  J D Chen; K Umesono; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

9.  Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor.

Authors:  G X Tong; M Jeyakumar; M R Tanen; M K Bagchi
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

10.  Two silencing sub-domains of v-erbA synergize with each other, but not with RXR.

Authors:  B Martin; R Renkawitz; M Muller
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.